Search
 
Home| Join Our Mailing List| New Reviews| New Titles
Editor's Choice| Bestsellers| Textbooks| Book Series| Study Guides| E-Catalogues
  CHEMISTRY
  Analytical Chemistry
Biochemistry
Computational Chemistry
Environmental/ Atmospheric
Chemistry

General
Inorganic Chemistry
Organic Chemistry
Physical Chemistry
New Titles
April Bestsellers
Editor's Choice
Nobel Lectures in Chemistry
Textbooks
Recent Reviews
Book Series
Related Journals
  • Surface Review and Letters (SRL)
  • Journal of Theoretical and Computational Chemistry (JTCC)
  • Chemistry Journals
  • NANO
  • Request for related catalogues
     
      PRODUCTS
      Journals
    eBooks
    Journals Archives
    eProceedings
     
      RESOURCES
      Print flyer
  • Full Version
  • Condensed Version
  • Recommend title
    Request for Inspection copy
    For Librarians
    For Authors
    For Booksellers
    For Translation Rights About Us
    Contact Us
    How to Order News
     
    Bookmark and Share

    HANDBOOK OF IMMUNOLOGICAL PROPERTIES OF ENGINEERING NANOMATERIALS

    edited by Marina A Dobrovolskaia (SAIC-Frederick Inc., USA) & Scott E McNeil (SAIC-Frederick Inc., USA)

    About Marina A Dobrovolskaia

    About Scott E McNeil


    The Handbook of Immunological Properties of Engineering Nanomaterials provides a comprehensive overview of current literature, methodologies, translational and regulatory considerations in the field of nanoimmunotoxicology. The main subject is immunological properties of engineered nanomaterials. The focus areas include interactions between engineered nanomaterials and red blood cells, platelets, endothelial cells, professional phagocytes, T cells, B cells, Dendritic cells, complement and coagulation systems, interaction with plasma proteins, nanoparticle sterility and sterilization. Each chapter includes a comprehensive literature review of a given area; describes protocols and resources available to support research in individual focus area; highlights challenges; and outlines unanswered questions and future directions. In addition, the handbook provides an overview and a practical guide to physicochemical characterization of engineered nanomaterials essential to conducting meaningful immunological studies of nanoparticles.

    The handbook also reviews regulations related to immunotoxicity testing of materials prior to their translation into clinic. It is written by top experts in the field of nanomedicine, nanotechnology and translational bionanotechnology representing academia, government, industry, consulting organizations and regulatory agencies. The handbook is designed to serve as a textbook for students, a practical guide for research laboratories and an informational resource for scientific consultants, reviewers and policy makers. It is written such that both experts and beginners will find useful information.

     
    Contents:
    • Introduction (Marina Dobrovolskaia and Scott McNeil)
    • Importance of Physicochemical Characterization Prior to Immunological Studies (Jeffrey Clogston)
    • Sterility and Sterilization of Nanomaterials (Nanda Subbarao)
    • Endotoxin and Engineered Nanomaterials (Marina Dobrovolskaia and Scott McNeil)
    • Surface Contaminants and Their Role in Nanoparticle Immunotoxicity (David Grainger)
    • Interaction with Plasma Proteins as It Relates to Particle Biodistribution (Ulrich Nienhaus and Lennart Treuel)
    • Effects on Erythrocytes (Ronald Brown)
    • Effects on Endothelial Cells (Jan Simak)
    • Effects on Plasma Coagulation System (Jan Simak)
    • Effects on Platelets (Jan Simak)
    • Complement Activation (Carolina Salvador-Morales and Robert Sim)
    • Effects on Macrophages and MPS Uptake (William Zamboni)
    • Effects on Dendritic Cells (Valentina Fesenkova)
    • Effects on Bone Marrow Cells (Ekaterina Dadachova)
    • Nanoparticles and Vaccine Delivery and Efficacy (Magdalena Plebanski)
    • Nanoparticles in Treatment of Inflammation-Associated Disorders (Deepthy Menon)
    • Allergy and Hypersensitivity (Africa Gonzalez-Fernandez)
    • Nanoparticles and Antigenicity (Marina Dobrovolskaia)
    • In Vitro Assays to Monitor Nanoparticle Interaction with Components of the Immune System (Marina Dobrovolskaia and Scott McNeil)
    • Animal Models to Monitor Adverse Effects of Nanomaterials on the Immune System (Dori Germolec et al.)
    • Regulatory Considerations (James Weaver)
     
    Readership: Researchers, academics, undergraduates and graduates in toxicology, immunotoxicology and nanomedicine, and industry (small and mid biotech companies and big pharmaceutical companies), as well as regulatory agencies (EPA, FDA) and physicians.
     
    “Understanding the immunogenicity of novel, engineered nanoparticle-based drugs is absolutely critical in bringing a nanomedicine into the clinic. Nanomedicines may activate the immune system or be invisible to it; the choice depends on the application. But, regardless, the mechanism of nanoparticle-immune interaction needs to be well understood and controlled. And this Handbook is an absolutely essential reference for those designing, developing or testing novel nanomedicines.”
    Lawrence Tamarkin
    President & CEO, CytImmune
     
    “One of the most overlooked areas in nanomedicine development is the study of the interaction of the host immune system with these novel constructs. Recognizing that the immune system has evolved over millennia to eliminate threats in the form of pathogenic organisms that are often in the 'nano' range, it is imperative that scientists and developers of nanomaterials engineered for in vivo use, understand this formidable barrier while trying to exploit the field. Dobrovolskaia and McNeil have put together an impressive collection of ‘must-read’ chapters from the experts that should inform the motivated nanotechnologists and provide a roadmap to avoid major stumbling blocks in the efforts to develop new nanomedicines. I wish I had such a guide to refer to during the early development of Abraxane.”
    Neil Desai
    Inventor, Abraxane and the nab-platform
    Abraxis Bioscience, A wholly owned subsidiary of Celgene Corporation
     
    850pp (approx.)    Pub. date: Scheduled Winter 2012  
    ISBN:   978-981-4390-25-5
    981-4390-25-9
       US$188 / £124

     


     

    Imperial College Press  |  Global Publishing  |  Asia-Pacific Biotech News  |  Innovation Magazine
    Labcreations Co  |  Meeting Matters  |  National Academies Press

    Copyright © 2012 World Scientific Publishing Co. All rights reserved.
    Updated on 16 May 2012